135 related articles for article (PubMed ID: 2908594)
1. Detection of central nervous system involvement in patients with leukemia or non-Hodgkin's lymphoma by immunological marker analysis of cerebrospinal fluid cells.
Hooijkaas H; Adriaansen HJ; van Dongen JJ
Cancer Treat Res; 1988; 38():149-71. PubMed ID: 2908594
[No Abstract] [Full Text] [Related]
2. Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies.
Kersten MJ; Evers LM; Dellemijn PL; van den Berg H; Portegies P; Hintzen RQ; van Lier RA; von dem Borne AE; van Oers RH
Blood; 1996 Mar; 87(5):1985-9. PubMed ID: 8634448
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid neopterin levels in children with central nervous system leukemia.
Millot F; Dhondt JL; Mazingue F; Mechinaud F; Auget JL; Bauters F; Harousseau JL
Leuk Lymphoma; 1993 Mar; 9(4-5):351-6. PubMed ID: 8348070
[TBL] [Abstract][Full Text] [Related]
4. Levels of serum and cerebrospinal fluid soluble CD27 in the diagnosis of leptomeningeal involvement of hematolymphoid malignancies.
Kara IO; Sahin B; Gunesacar R
Adv Ther; 2007; 24(4):741-7. PubMed ID: 17901023
[TBL] [Abstract][Full Text] [Related]
5. Immunophenotyping of leukaemias and non-Hodgkin's lymphomas. Immunological markers and their CD codes.
van Dongen JJ; Adriaansen HJ; Hooijkaas H
Neth J Med; 1988 Dec; 33(5-6):298-314. PubMed ID: 3265488
[No Abstract] [Full Text] [Related]
6. Terminal deoxynucleotidyl transferase (TdT)-positive cells in cerebrospinal fluid and development of overt CNS leukemia: a 5-year follow-up study in 113 children with a TdT-positive leukemia or non-Hodgkin's lymphoma.
Hooijkaas H; Hählen K; Adriaansen HJ; Dekker I; van Zanen GE; van Dongen JJ
Blood; 1989 Jul; 74(1):416-22. PubMed ID: 2752121
[TBL] [Abstract][Full Text] [Related]
7. [A form of "creeping" involvement of the central nervous system in lymphoblastic leukemia and non-Hodgkin's malignant lymphoma in children].
Kubiczek K; Rytlewska M; Dłuzniewska A; Grotyński M; Kałuza J
Pol Tyg Lek; 1987 Aug; 42(33):1012-5. PubMed ID: 3480509
[No Abstract] [Full Text] [Related]
8. Immunologic approaches to the classification of non-Hodgkin's lymphomas.
Grogan TM; Spier CM; Richter LC; Rangel CS
Cancer Treat Res; 1988; 38():31-148. PubMed ID: 2908600
[No Abstract] [Full Text] [Related]
9. Acute leukemia with extramedullary presentation and mixed myeloid and lymphoid expression.
Bayle C; Romdhane NB; Bastard C; Vannier JP; Hayat M; Lemerle J; Bernard A
Pediatr Hematol Oncol; 1986; 3(3):293-6. PubMed ID: 3153242
[No Abstract] [Full Text] [Related]
10. Immunologic approaches to the classification of lymphomas and lymphoid leukemias.
Foon KA; Gale RP; Todd RF
Cancer Treat Res; 1988; 38():1-30. PubMed ID: 2908593
[No Abstract] [Full Text] [Related]
11. Protein biomarker identification in the CSF of patients with CNS lymphoma.
Roy S; Josephson SA; Fridlyand J; Karch J; Kadoch C; Karrim J; Damon L; Treseler P; Kunwar S; Shuman MA; Jones T; Becker CH; Schulman H; Rubenstein JL
J Clin Oncol; 2008 Jan; 26(1):96-105. PubMed ID: 18056677
[TBL] [Abstract][Full Text] [Related]
12. [Terminal deoxynucleotidyltransferase (TdT)-positive cells in cerebrospinal fluid of children with leukemia or non-Hodgkin lymphoma: implications for the diagnosis of central nervous system leukemia].
Hooijkaas H; Adriaansen HJ; Hählen K; van Zanen GE; van Dongen JJ
Tijdschr Kindergeneeskd; 1986 Apr; 54(2):46-50. PubMed ID: 3520947
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid beta-2-microglobulin in adult patients with acute leukemia or lymphoma: a useful marker in early diagnosis and monitoring of CNS-involvement.
Hansen PB; Kjeldsen L; Dalhoff K; Olesen B
Acta Neurol Scand; 1992 Mar; 85(3):224-7. PubMed ID: 1575009
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and immunologic diagnosis of cancer. Central nervous system tumors.
Collins VP
Tumour Biol; 1987; 8(2-3):147-50. PubMed ID: 3329397
[No Abstract] [Full Text] [Related]
15. Tumor necrosis factor in the cerebrospinal fluid of children with central nervous system leukemia.
Ishii E; Ohga S; Murano I; Kobayashi M; Kimura K; Eguchi H; Akazawa K; Ueda K
Leuk Res; 1991; 15(2-3):143-7. PubMed ID: 1901928
[TBL] [Abstract][Full Text] [Related]
16. [Cerebrospinal fluid cytological observations made in the course of meningeal, blastamatous processes].
Kulczycki J; Olischer RM; Osuch Z
Psychiatr Neurol Med Psychol (Leipz); 1974 Nov; 26(11):676-84. PubMed ID: 4615328
[No Abstract] [Full Text] [Related]
17. Detection of residual disease in acute leukemia using immunological markers.
Ryan DH; van Dongen JJ
Cancer Treat Res; 1988; 38():173-207. PubMed ID: 2908595
[No Abstract] [Full Text] [Related]
18. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989.
Miller DC; Hochberg FH; Harris NL; Gruber ML; Louis DN; Cohen H
Cancer; 1994 Aug; 74(4):1383-97. PubMed ID: 8055462
[TBL] [Abstract][Full Text] [Related]
19. Tumour markers in the cerebrospinal fluid of patients with central nervous system metastases from extracranial malignancies.
van Zanten AP; Twijnstra A; Ongerboer de Visser BW; Hart AA; Nooyen WJ
Clin Chim Acta; 1988 Jul; 175(2):157-66. PubMed ID: 3409530
[TBL] [Abstract][Full Text] [Related]
20. Longterm meningeal involvement as the only clinical manifestation of low grade malignant non-Hodgkin's lymphoma.
Heimans JJ; Wijermans PW; Polman CH; Huijgens PC; Ossenkoppele GJ; van Kamp GJ
J Neurooncol; 1990 Dec; 9(3):275-7. PubMed ID: 2086741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
